🚀 VC round data is live in beta, check it out!
eXoZymes Valuation Multiples
Discover revenue and EBITDA valuation multiples for eXoZymes and similar public comparables like IBU-tec adv materials, Holland, Baikowski, QB Industrias and more.
eXoZymes Overview
About eXoZymes
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
Founded
2019
HQ
Employees
31
Website
Sectors
Financials (FY)
EV
$88M
eXoZymes Financials
eXoZymes reported last fiscal year revenue of — and negative EBITDA of ($9M).
In the same fiscal year, eXoZymes generated ($9M) in EBITDA losses and had net loss of ($9M).
eXoZymes P&L
In the most recent fiscal year, eXoZymes reported revenue of — and EBITDA of ($9M).
eXoZymes expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($9M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($9M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
eXoZymes Stock Performance
eXoZymes has current market cap of $90M, and enterprise value of $88M.
Market Cap Evolution
eXoZymes' stock price is $10.60.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $88M | $90M | 0.0% | XXX | XXX | XXX | $-1.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialeXoZymes Valuation Multiples
eXoZymes trades at (9.3x) EV/EBITDA.
eXoZymes Financial Valuation Multiples
As of April 20, 2026, eXoZymes has market cap of $90M and EV of $88M.
Equity research analysts estimate eXoZymes' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
eXoZymes has a P/E ratio of (9.8x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $90M | XXX | $90M | XXX | XXX | XXX |
| EV (current) | $88M | XXX | $88M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (9.3x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (9.1x) | XXX | XXX | XXX |
| P/E | — | XXX | (9.8x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (13.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified eXoZymes Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
eXoZymes Margins & Growth Rates
eXoZymes' revenue in the last fiscal year grew by —.
eXoZymes' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.
eXoZymes Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 66% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
eXoZymes Public Comps
See public comps and valuation multiples for other Chemicals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| eXoZymes | XXX | XXX | XXX | XXX | XXX | XXX |
| IBU-tec adv materials | XXX | XXX | XXX | XXX | XXX | XXX |
| Holland | XXX | XXX | XXX | XXX | XXX | XXX |
| Baikowski | XXX | XXX | XXX | XXX | XXX | XXX |
| QB Industrias | XXX | XXX | XXX | XXX | XXX | XXX |
| Quimpac | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
eXoZymes M&A Activity
eXoZymes acquired XXX companies to date.
Last acquisition by eXoZymes was on XXXXXXXX, XXXXX. eXoZymes acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by eXoZymes
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialeXoZymes Investment Activity
eXoZymes invested in XXX companies to date.
eXoZymes made its latest investment on XXXXXXXX, XXXXX. eXoZymes invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by eXoZymes
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout eXoZymes
| When was eXoZymes founded? | eXoZymes was founded in 2019. |
| Where is eXoZymes headquartered? | eXoZymes is headquartered in United States. |
| How many employees does eXoZymes have? | As of today, eXoZymes has over 31 employees. |
| Who is the CEO of eXoZymes? | eXoZymes' CEO is Michael Heltzen. |
| Is eXoZymes publicly listed? | Yes, eXoZymes is a public company listed on Nasdaq. |
| What is the stock symbol of eXoZymes? | eXoZymes trades under EXOZ ticker. |
| When did eXoZymes go public? | eXoZymes went public in 2024. |
| Who are competitors of eXoZymes? | eXoZymes main competitors are IBU-tec adv materials, Holland, Baikowski, QB Industrias. |
| What is the current market cap of eXoZymes? | eXoZymes' current market cap is $90M. |
| Is eXoZymes profitable? | No, eXoZymes is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.